Effect of SGLT2i on Cardiovascular Biomarkers in Patients With Type 2 Diabetes and CKD Stage 3b-4

NCT05033054 · clinicaltrials.gov ↗

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Kidney Disease, Chronic
Diabetes

Interventions

DRUG: SGLT2 inhibitor

Sponsor

University of Texas Southwestern Medical Center